TY - JOUR AU - Papandreou, Christopher AU - Bullò, Mònica AU - Tinahones, Francisco José AU - Martínez-González, Miguel Ángel AU - Corella, Dolores AU - Fragkiadakis, Georgios A. AU - López-Miranda, José AU - Estruch, Ramon AU - Fitó, Montserrat AU - Salas-Salvadó, Jordi PY - 2017 DA - 2017/09/02 TI - Serum metabolites in non-alcoholic fatty-liver disease development or reversion; a targeted metabolomic approach within the PREDIMED trial JO - Nutrition & Metabolism SP - 58 VL - 14 IS - 1 AB - Limited prospective studies have examined changes in non-alcoholic fatty-liver disease (NAFLD) related serum-metabolites and none the effects of NAFLD-reversion. We aimed to evaluate whether perturbations in metabolites indicate predisposition to NAFLD development and to assess the effects of NAFLD reversion on metabolite profiles. SN - 1743-7075 UR - https://doi.org/10.1186/s12986-017-0213-3 DO - 10.1186/s12986-017-0213-3 ID - Papandreou2017 ER -